The kinetics of competitive antagonism by cisatracurium of embryonic and adult nicotinic acetylcholine receptors

Molecular Pharmacology

Volumn 60, Issue 4, 2001, Pages 797-807

  Demazumder, D ^a   Dilger, J P ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CISATRACURIUM; MUSCLE RELAXANT AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; PANCURONIUM; TUBOCURARINE CHLORIDE;

ADULT; AGE; ARTICLE; BINDING KINETICS; COMPETITIVE INHIBITION; COMPUTER SIMULATION; CONTROLLED STUDY; DISSOCIATION; DRUG BINDING SITE; DRUG RECEPTOR BINDING; EMBRYO; HUMAN; HUMAN CELL; MATHEMATICAL ANALYSIS; PRIORITY JOURNAL;

ACETYLCHOLINE; ANIMALS; ATRACURIUM; BINDING, COMPETITIVE; CELLS, CULTURED; COMPUTER SIMULATION; ELECTROPHYSIOLOGY; EMBRYO; KINETICS; MICE; NEUROMUSCULAR BLOCKING AGENTS; NICOTINIC ANTAGONISTS; RECEPTORS, NICOTINIC;

EID: 0034813320     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. The muscarinic antagonists aprophen and benactyzine are noncompetitive inhibitors of the nicotinic acetylcholine receptor
2. Inhibition of ionotropic neurotransmitter receptors by antagonists: Strategy to estimate the association and the dissociation rate constant of antagonists with very strong affinity to the receptors
3. Localization of agonist and competitive antagonist binding sites on nicotinic acetylcholine receptors
4. Desensitization of mouse nicotinic acetylcholine receptor channels. A two-gate mechanism
5. Thermodynamics of the interaction of d-tubocurarine with nicotinic receptors of mammalian skeletal muscle in vitro
6. Cisatracurium besilate. A review of its pharmacology and clinical potential in anaesthetic practice
7. Open channel and competitive block of the embryonic form of the nicotinic receptor of mouse myotubes by p-tubocurarine
8. Open-channel blockers at the human α4β2 neuronal nicotinic acetylcholine receptor
9. The actions of tubocurarine at the frog neuromuscular junction
10. The effect of tubocurarine competition on the kinetics of agonist action on the nicotinic receptor
11. Equilibrium binding of cholinergic ligands to the membrane-bound acetylcholine receptor
12. Structure and function of the nicotinic acetylcholine receptor
13. Direct measurement of the concentration- and time-dependent open probability of the nicotinic acetylcholine receptor channel
14. Ability of nondepolarizing neuromuscular blocking drugs to act as partial agonists at fetal and adult mouse muscle nicotinic receptors
15. Speed of action of various muscle relaxants at the neuromuscular junction binding vs. buffering hypothesis
16. Mapping the conformational wave of acetylcholine receptor channel gating
17. Pharmacokinetics and pharmacodynamics of d-tubocurarine during hypothermia in the cat
18. Neuromuscular relaxants as antagonistsfor M2 and M3 muscarinic receptors
19. Pancuronium, gallamine, and d-tubocurarine compared: Is speed of onset inversely related to drug potency?
20. Molar potency is predictive of the speed of onset of neuromuscular block for agents of intermediate, short, and ultrashort duration
21. Kinetics of D-tubocurarine blockade at the neuromuscular junction
22. Hypothermia and the pharmacokinetics and pharmacodynamics of pancuronium in the cat
23. Nicotinic acetylcholine receptor at 4.6 Å resolution: Transverse tunnels in the channel wall
24. Single channel currents at six microsecond resolution elicited by acetylcholine in mouse myoballs
25. The margin of safety of neuromuscular transmission
26. Molecular dissection of subunit interfaces in the acetylcholine receptor. Identification of residues that determine agonist selectivity
27. Acetylcholine receptors
28. Pharmacology of muscle relaxants and their antagonists
29. Characterization of a unique muscle cell line
30. Interactions of d-tubocurarine with the nicotinic acetylcholine receptor/channel molecule
31. Activation of a nicotinic acetylcholine receptor
32. Activation of acetylcholine receptors on clonal mammalian BC3H-1 cells by low concentrations of agonist
33. Relationship between reversible antagonist occupancy and the functional capacity of the acetylcholine receptor
34. Identification of drugs competing with d-tubocurarine for an allosteric site on cardiac muscarinic receptors
35. Comparative pharmacology of cisatracurium (51W89), atracurium, and five isomers in cats
36. The kinetics of inhibition of nicotinic acetylcholine receptors by D-tubocurarine and pancuronium
37. The effect of temperature on the action of several neuromuscular blocking agents in vitro
38. Activation of recombinant mouse acetylcholine receptors by acetylcholine, carbamylcholine and tetramethylammonium
39. 2+ entry